Journal of Parkinsons Disease

Papers
(The H4-Index of Journal of Parkinsons Disease is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention142
When Parkinson's disease interferes in a couple's life: A qualitative study112
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?85
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists70
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease68
A framework to standardize gait study protocols in Parkinson's disease66
Clinical Trial Highlights: Modulators of Mitochondrial Function62
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression58
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients56
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”56
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort56
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders50
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review48
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder48
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease48
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”47
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease47
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease46
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease44
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy43
No Higher Risk-Seeking Tendencies or Altered Self-Estimation in a Social Decision-Making Task in Patients with Parkinson’s Disease42
What medicines do people with Parkinson's disease want?41
The fixel GI Parkinson's research and integrated support model (PRISM)38
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease38
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease37
A possible pathway to freezing of gait in Parkinson's disease35
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis35
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease35
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative34
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?34
Are Preformed Fibrils a Model of Parkinson’s Disease?33
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease33
0.15201997756958